Publication | Closed Access
Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer’s disease
82
Citations
28
References
2016
Year
Cannabis UseNeurodegenerative DiseasesAlzheimer's DiseaseMedicineCannabinoid Type 2Vivo AvailabilityNeuropharmacologyAlzheimer ’NeurologyNeuroscienceLewy Body DementiaPharmacologyCannabinoid PharmacologyCannabinoidsSocial SciencesCannabis
| Year | Citations | |
|---|---|---|
Page 1
Page 1